Tambus, Michael .

HRN: 22-81-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
CEFUROXIME 750MG (VIAL)
03/28/2023
04/04/2023
IV
750 Mg
Q8hrs
T/C Testicular Rupture

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines